Alberto Álvarez-Larrán

25PUBLICATIONS
113CO-AUTHORS
Haematological tumoursEpidemiological modellingHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

|Nov 24, 2025
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.

Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

|Sep 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia.

Marta Santaliestra, Marta Garrote, María Soledad Noya

|Apr 08, 2024
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.

Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Alberto Alvarez-Larrán

|Aug 30, 2023
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.

Giovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline

Pageof 5

Frequent Collaborators

12 joint publications

Juan-Carlos Hernández-Boluda

9 joint publications

Francisca Ferrer-Marin

7 joint publications

Valentín García-Gutiérrez

5 joint publications

Gonzalo Carreño-Tarragona